Rznomics Secures Third Research Payment from Eli Lilly, Advancing RNA-Editing Therapies for Hereditary Hearing Loss
SEONGNAM, SOUTH KOREA – Rznomics, a pioneering South Korean biotechnology company, has received an additional research payment from global pharmaceutical giant Eli Lilly and…
